New shot aims to tame COPD Flare-Ups in inflammatory subtype
NCT ID NCT06940154
First seen Jun 25, 2026 · Last updated Jul 14, 2026 · Updated 3 times
Summary
This Phase 2 trial tests whether rademikibart, an injected drug, can help adults with COPD who are having a sudden flare-up and have a specific type of inflammation (type 2). The study will compare the drug to a placebo in 160 participants, looking at whether it reduces treatment failure—like hospital readmission or needing more steroids—within 28 days.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- rademikibart (also called CBP-201), a drug given as a shot
- What this could lead to
- If it works, this could point toward a new add-on treatment to reduce hospital visits and treatment failure during COPD flare-ups.
- What could go wrong
- This is an early Phase 2 trial with only 160 people, so results may not apply to everyone. The drug is experimental and may not work better than placebo.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COPD ACUTE EXACERBATION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Acad. Chapidze Emergency Cardiology Center LLC
Tbilisi, 0159, Georgia
-
Acad. G. Chapidze Emergency Cardiology Center
Tbilisi, 0159, Georgia
-
Amicis Research Center
Valencia, California, 91355, United States
-
Bendigo Health
Bendigo, Victoria, 3550, Australia
-
CEMER - Centro Medico de Enfermedades Respiratorias
Florida, Buenos Aires, B1602, Argentina
-
Campbelltown Hospital
Campbelltown, New South Wales, 2560, Australia
-
Carilion Medical Center / Carilion Roanoke Memorial Hospital
Roanoke, Virginia, 24014, United States
-
Caucasus Medical Center
Tbilisi, 0159, Georgia
-
Centro Medico Ipam S.A
Rosario, Santa Fe Province, S2000, Argentina
-
Centro de Diagnostivo y Rehabilitación S.A. - CEDIR
Santa Fe, S3000, Argentina
-
Centro de Investigaciones Médicas Mar del Plata
Mar del Plata, Buenos Aires, B7600FYK, Argentina
-
Clinical Hospital Center "Dragisa Misovic - Dedinje"
Belgrade, 11040, Serbia
-
Clinical Research of Rock Hill
Rock Hill, South Carolina, 29732, United States
-
Columbus Clinical Services, LLC
Miami, Florida, 33125, United States
-
DCT- McAllen Primary Care Research, LLC dba Discovery Clinical Trials
McAllen, Texas, 78503, United States
-
Duke Asthma, Allergy, and Airway Center
Durham, North Carolina, 27705, United States
-
Guy's and St Thomas NHS Foundation Trust
London, SE1 7EH, United Kingdom
-
Health Center Uzice
Užice, 31000, Serbia
-
Health Synergy Clinical Research, LLC
West Palm Beach, Florida, 33407, United States
-
Hospital Italiano de Buenos Aires
CABA, Buenos Aires, C1199, Argentina
-
Hospital Universitario Austral
Pilar, Buenos Aires, 1629, Argentina
-
Inquest Clinical Research
Baytown, Texas, 77521, United States
-
Institute for Pulmonary Diseases and Tuberculosis Nis
Niš, 18108, Serbia
-
Institute for Pulmonary Diseases of Vojvodina
Kamenitz, 21204, Serbia
-
Institute for Respiratory Health
Nedlands, Western Australia, 6009, Australia
-
Instituto Ave Pulmo-Fundacion Enfisema
Mar del Plata, Buenos Aires, 7600, Argentina
-
Investigaciones en Patologias Respiratorias SRL
San Miguel de Tucumán, Tucumán Province, 4000, Argentina
-
JSC "National Center for Lung Health"
Tbilisi, 0101, Georgia
-
LLC "Israel-Georgian Medical Research Clinic Healthycore"
Tbilisi, 0112, Georgia
-
LLC Diacor
Tbilisi, 0159, Georgia
-
Leland Stanford Junior University, Stanford Hospital
Palo Alto, California, 94304, United States
-
Medicines Evaluation Unit Ltd.
Wythenshawe, Greater Manchester, M23 9QZ, United Kingdom
-
National Jewish Health
Denver, Colorado, 80206, United States
-
Ochsner Medical Complex - The Grove
Baton Rouge, Louisiana, 70836, United States
-
Pharmax Research of South Florida, Inc.
Miami, Florida, 33175, United States
-
Pivotal Research Solutions
Stonecrest, Georgia, 30038, United States
-
Premier Pulmonary Critical Care and Sleep Medicine
Denison, Texas, 75020, United States
-
Primeway Clinical Research Group
Fayetteville, Georgia, 30214, United States
-
Queen Elizabeth hospital Birmingham
Birmingham, B15 2GW, United Kingdom
-
Salford Royal Hospital - Northern Care Alliance NHS Foundation Trust Barnes Clinical Research Facility
Salford, M6 8HD, United Kingdom
-
St. Vincent's Hospital Sydney
Darlinghurst, New South Wales, 2010, Australia
-
Stony Brook University Hospital
Stony Brook, New York, 11733, United States
-
Sunshine Coast University Hospital
Birtinya, Queensland, 4575, Australia
-
The Canberra Hospital
Garran, Australian Capital Territory, 2605, Australia
-
The Ohio State University Wexner Medical Center
Columbus, Ohio, 43210, United States
-
University Clinical Center Kragujevac
Kragujevac, 34000, Serbia
-
University Hospitals Birmingham NHS Foundation Trust Birmingham Heartlands Hospital
Birmingham, B9 5SS, United Kingdom
-
University of Alabama at Birmingham Lung Health Center
Birmingham, Alabama, 35233, United States
-
University of Iowa
Iowa City, Iowa, 52242, United States
-
University of Kansas Medical Center
Kansas City, Kansas, 66160, United States
-
Vermont Lung Center
Colchester, Vermont, 05446, United States
-
Westmead Hospital
Westmead, New South Wales, 2145, Australia
More trials for these conditions
Other studies related to the condition(s) this trial covers.